drugset / Trial / NCT00234949

A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections

NCT00234949

Phase 4 Completed 380 enrolled Abbott
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy and tolerability of cefdinir to that of cephalexin in patients with mild to moderate uncomplicated skin/skin structure infections.

Timeline

Start
2005-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject CEPHALEXIN ANHYDROUS Small molecule
Subject cefdinir Other / unclassified

Indications

No indication recorded.